Drug Discovery & Development

Congressional inaction has led to the expiration of the federal government’s SBIR/STTR program, cutting off a biotechnology lifeline.

A series of rodent experiments showed that even with abundant food and water, personal space is essential to prevent societal collapse, but Universe 25's relevance to humans remains disputed.

Studying over 100,000 embryos revealed genetic factors behind chromosome segregation issues that lead to aneuploidy, informing future risk screening and intervention.

Promoting brown fat activity could counteract hypertension by reshaping the molecular signals that govern vascular stiffness.

In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.

In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.